New data shows Alzheimer's drug can benefit some patients
04:58
Share this -
copied
Dr. Madhav Thambisetty of Johns Hopkins School of Medicine joins Morning Joe to discus the results of a clinical trial of an experimental Alzheimer’s drug that suggest that the treatment slowed cognitive decline somewhat for people in the early stages of the disease.Nov. 30, 2022
UP NEXT
Rev. Al: We will stand and fight in the name of Tyre Nichols
11:04
The RNC is doubling down on two failed strategies
04:56
Tom Brady announces he's retiring for good
07:37
Joe: Why should Biden negotiate against himself on the debt ceiling?
11:40
Elie Honig: Trump hush money probe has come roaring back to life
12:17
How Republicans are employing magical thinking with Trump